1. Home
  2. GSBC vs REPL Comparison

GSBC vs REPL Comparison

Compare GSBC & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Great Southern Bancorp Inc.

GSBC

Great Southern Bancorp Inc.

HOLD

Current Price

$68.15

Market Cap

746.4M

Sector

Finance

ML Signal

HOLD

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

HOLD

Current Price

$5.34

Market Cap

692.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSBC
REPL
Founded
1923
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
746.4M
692.8M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
GSBC
REPL
Price
$68.15
$5.34
Analyst Decision
Hold
Hold
Analyst Count
1
9
Target Price
$65.00
$5.67
AVG Volume (30 Days)
94.3K
8.1M
Earning Date
04-15-2026
05-21-2026
Dividend Yield
2.54%
N/A
EPS Growth
17.68
5.25
EPS
1.58
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.56
N/A
P/E Ratio
$43.35
N/A
Revenue Growth
N/A
N/A
52 Week Low
$53.76
$1.50
52 Week High
$70.91
$13.24

Technical Indicators

Market Signals
Indicator
GSBC
REPL
Relative Strength Index (RSI) 52.15 62.53
Support Level $60.23 $4.39
Resistance Level $70.91 $5.84
Average True Range (ATR) 1.57 0.53
MACD -0.20 0.43
Stochastic Oscillator 44.98 96.61

Price Performance

Historical Comparison
GSBC
REPL

About GSBC Great Southern Bancorp Inc.

Great Southern Bancorp Inc is a bank holding company. Through its subsidiaries, the company mainly offers a variety of banking and banking-related services, such as accepting deposits, granting loans and advances, offering mobile banking services, issuing debit and credit cards, safe deposit boxes, ATM facilities, and other related products and services. These services are offered through full-service retail banking offices and loan production offices located across different states in the U.S., including Missouri, Iowa, Kansas, Minnesota, Nebraska, Arkansas, and others.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Share on Social Networks: